The Randle cycle revisited: a new head for an old hat.
暂无分享,去创建一个
[1] N. Ruderman,et al. AMPK and the biochemistry of exercise: implications for human health and disease. , 2009, The Biochemical journal.
[2] J. Enríquez,et al. Respiratory active mitochondrial supercomplexes. , 2008, Molecular cell.
[3] C. Kahn,et al. Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle. , 2008, Endocrinology.
[4] M. Rigoulet,et al. Mitochondrial Oxidative Phosphorylation Is Regulated by Fructose 1,6-Bisphosphate , 2008, Journal of Biological Chemistry.
[5] G. Shulman,et al. Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle , 2008, Diabetes.
[6] Ashish Gangasani,et al. Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice. , 2008, American journal of physiology. Heart and circulatory physiology.
[7] J. Hoek,et al. Regulation of hexokinase binding to VDAC , 2008, Journal of bioenergetics and biomembranes.
[8] C. R. Wilson,et al. Adaptation and Maladaptation of the Heart in Obesity , 2008, Hypertension.
[9] R. Schwenk,et al. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. , 2008, Cardiovascular research.
[10] Robert A. Harris,et al. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. , 2008, American journal of physiology. Endocrinology and metabolism.
[11] Peter Tontonoz,et al. Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.
[12] K. Sakamoto,et al. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. , 2008, American journal of physiology. Endocrinology and metabolism.
[13] David Goff,et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. , 2008, Hypertension.
[14] Michael E. Lassman,et al. Malonyl CoenzymeA Decarboxylase Regulates Lipid and Glucose Metabolism in Human Skeletal Muscle , 2008, Diabetes.
[15] V. Zammit. Carnitine palmitoyltransferase 1: Central to cell function , 2008, IUBMB life.
[16] J. Girard,et al. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. , 2008, The Journal of clinical investigation.
[17] M. Laakso,et al. Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance , 2008, Cell.
[18] Robert A. Harris,et al. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.
[19] B. Morio,et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. , 2008, The Journal of clinical investigation.
[20] Xianlin Han,et al. Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart , 2007 .
[21] Robert V Farese,et al. Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. , 2007, American journal of physiology. Endocrinology and metabolism.
[22] P. Razeghi,et al. Proposed Regulation of Gene Expression by Glucose in Rodent Heart , 2007, Gene regulation and systems biology.
[23] S. Wakil,et al. Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity , 2007, Proceedings of the National Academy of Sciences.
[24] D. Hardie,et al. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.
[25] C. R. Wilson,et al. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. , 2007, The Biochemical journal.
[26] M. Watford,et al. Leucing weight with a futile cycle. , 2007, Cell metabolism.
[27] X. Leverve. Mitochondrial function and substrate availability , 2007, Critical care medicine.
[28] M. Rider,et al. The AMP-activated protein kinase: more than an energy sensor. , 2007, Essays in biochemistry.
[29] J. Girard,et al. ChREBP, a transcriptional regulator of glucose and lipid metabolism. , 2007, Annual review of nutrition.
[30] J. Pessin,et al. Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking. , 2007, Current opinion in cell biology.
[31] J. Auwerx,et al. PPARγ in human and mouse physiology , 2007 .
[32] Robert V Farese,et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. , 2007, Cell metabolism.
[33] S. Kersten,et al. PPARα and dyslipidemia , 2007 .
[34] R. Zivadinov. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? , 2007, Neurology.
[35] Jimmy D Bell,et al. The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance , 2007, Nuclear receptor.
[36] R. Marchase,et al. Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. , 2007, American journal of physiology. Heart and circulatory physiology.
[37] M. Sugden. In appreciation of Sir Philip Randle: the glucose-fatty acid cycle. , 2007, The British journal of nutrition.
[38] Xianlin Han,et al. CD36 Deficiency Rescues Lipotoxic Cardiomyopathy , 2007, Circulation research.
[39] S. Wakil,et al. Reduced Heart Size and Increased Myocardial Fuel Substrate Oxidation in ACC2 Mutant Mice , 2007, American journal of physiology. Heart and circulatory physiology.
[40] D. Carling,et al. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. , 2007, The Biochemical journal.
[41] K. Petersen,et al. Disordered lipid metabolism and the pathogenesis of insulin resistance. , 2007, Physiological reviews.
[42] F. Foufelle,et al. SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective , 2007, Hormone Research in Paediatrics.
[43] D. Kelly,et al. Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-&agr;/PGC-1&agr; Gene Regulatory Pathway , 2007, Circulation.
[44] D. Hardie,et al. AMP-activated protein kinase as a drug target. , 2007, Annual review of pharmacology and toxicology.
[45] K. Petersen,et al. Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction , 2006, Diabetes.
[46] P. Arner,et al. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. , 2006, Essays in biochemistry.
[47] K. Jishage,et al. Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury , 2006, Circulation.
[48] E. Disse,et al. Short-term activation of peroxysome proliferator-activated receptor β/δ increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients , 2006, Journal of Molecular Medicine.
[49] J. Repa,et al. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.
[50] B. Viollet,et al. Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. , 2006, American journal of physiology. Heart and circulatory physiology.
[51] G. Lopaschuk,et al. AMPK alterations in cardiac physiology and pathology: enemy or ally? , 2006, The Journal of physiology.
[52] B. Viollet,et al. AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.
[53] C. Newgard,et al. Obesity-related derangements in metabolic regulation. , 2006, Annual review of biochemistry.
[54] Ziwei Gu,et al. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] M. Rigoulet,et al. The ROS Production Induced by a Reverse-Electron Flux at Respiratory-Chain Complex 1 is Hampered by Metformin , 2006, Journal of bioenergetics and biomembranes.
[56] W. Wahli,et al. Transcriptional regulation of metabolism. , 2006, Physiological reviews.
[57] Alexander G. Gray,et al. Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation. , 2006, Molecular endocrinology.
[58] B. Finck. Effects of PPARα on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle? , 2006, Expert review of cardiovascular therapy.
[59] E. Disse,et al. Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells , 2006, Diabetologia.
[60] M. Holness,et al. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases , 2006, Archives of physiology and biochemistry.
[61] J. Hanover,et al. The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.
[62] Ping Li,et al. Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency* , 2005, Journal of Biological Chemistry.
[63] Ziwei Gu,et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] C. R. Wilson,et al. Metabolic Energetics and Genetics in the Heart , 2005, Annals of the New York Academy of Sciences.
[65] B. Viollet,et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. , 2005, Diabetes.
[66] J. Girard,et al. Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity. , 2005, The Biochemical journal.
[67] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[68] S. Chirala,et al. Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[69] J. Holloszy,et al. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. , 2005, Cell metabolism.
[70] É. Hajduch,et al. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. , 2004, The Biochemical journal.
[71] D. Vertommen,et al. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. , 2004, The Biochemical journal.
[72] David Carling,et al. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. , 2004, European journal of biochemistry.
[73] M. Chandler,et al. Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation , 2004, Circulation research.
[74] L. Golfman,et al. Linking Gene Expression to Function: Metabolic Flexibility in the Normal and Diseased Heart , 2004, Annals of the New York Academy of Sciences.
[75] David Millington,et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.
[76] D. Carling,et al. Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase. , 2003, Biochemical Society transactions.
[77] M. Holness,et al. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. , 2003, Biochemical Society transactions.
[78] K. Frayn. The glucose-fatty acid cycle: a physiological perspective. , 2003, Biochemical Society transactions.
[79] X. Leverve,et al. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. , 2003, Diabetes & metabolism.
[80] S. Wakil,et al. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[81] N. Ruderman,et al. Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. , 2003, Diabetes.
[82] Y. Le Marchand-Brustel,et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.
[83] M. Holness,et al. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. , 2003, American journal of physiology. Endocrinology and metabolism.
[84] H. Taegtmeyer. Switching Metabolic Genes to Build a Better Heart , 2002, Circulation.
[85] Jing He,et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.
[86] J. Tavaré,et al. The Identification of ATP-citrate Lyase as a Protein Kinase B (Akt) Substrate in Primary Adipocytes* , 2002, The Journal of Biological Chemistry.
[87] M. Prentki,et al. Coordinate Regulation of Malonyl-CoA Decarboxylase,sn-Glycerol-3-phosphate Acyltransferase, and Acetyl-CoA Carboxylase by AMP-activated Protein Kinase in Rat Tissues in Response to Exercise* , 2002, The Journal of Biological Chemistry.
[88] F. Foufelle,et al. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. , 2002, The Biochemical journal.
[89] J. Dyck,et al. Phosphorylation of cardiac protein kinase B is regulated by palmitate. , 2002, American journal of physiology. Heart and circulatory physiology.
[90] P. Razeghi,et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. , 2002, Diabetes.
[91] S. Eaton. Control of mitochondrial beta-oxidation flux. , 2002, Progress in lipid research.
[92] D. Severson,et al. A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.
[93] R. Evans,et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[94] O. Frazier,et al. Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.
[95] B. Kemp,et al. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. , 2001, Archives of biochemistry and biophysics.
[96] H. Taegtmeyer,et al. Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart* , 2001, The Journal of Biological Chemistry.
[97] M. Rigoulet,et al. The mitochondrial consequences of uncoupling intact cells depend on the nature of the exogenous substrate. , 2001, The Biochemical journal.
[98] Martin M. Matzuk,et al. Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.
[99] C. R. Wilson,et al. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. , 2001, American journal of physiology. Endocrinology and metabolism.
[100] G. Shipley,et al. Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] D. Carling,et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.
[102] H. Taegtmeyer,et al. Improved energy homeostasis of the heart in the metabolic state of exercise. , 2000, American journal of physiology. Heart and circulatory physiology.
[103] M. Prentki,et al. Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside* , 2000, The Journal of Biological Chemistry.
[104] J. Ward,et al. Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.
[105] L. Mandarino,et al. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. , 2000, Diabetes.
[106] M. Gibala,et al. Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle. , 2000, Acta physiologica Scandinavica.
[107] R. Harris,et al. Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression. , 2000, The Biochemical journal.
[108] S. Chirala,et al. The subcellular localization of acetyl-CoA carboxylase 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[109] S. Doronin,et al. Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. , 2000, Biochemistry.
[110] Rena R Wing,et al. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. , 1999, American journal of physiology. Endocrinology and metabolism.
[111] V. Zammit. The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. , 1999, The Biochemical journal.
[112] H. Taegtmeyer,et al. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. , 1999, American journal of physiology. Endocrinology and metabolism.
[113] G. Shulman,et al. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. , 1999, The American journal of physiology.
[114] Z Trajanoski,et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.
[115] W. Wahli,et al. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .
[116] D. Hardie,et al. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. , 1999, European journal of biochemistry.
[117] D L Rothman,et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.
[118] P. J. Randle,et al. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.
[119] M. Rider,et al. Mechanisms of control of heart glycolysis. , 1998, European journal of biochemistry.
[120] Margaret S. Wu,et al. Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. , 1998, Endocrinology.
[121] H. Taegtmeyer,et al. Regulation of Energy Metabolism of the Heart during Acute Increase in Heart Work* , 1998, The Journal of Biological Chemistry.
[122] M. Rigoulet,et al. Oxidative phosphorylation in intact hepatocytes: Quantitative characterization of the mechanisms of change in efficiency and cellular consequences , 1998, Molecular and Cellular Biochemistry.
[123] Eric Fontaine,et al. Quantitative analysis of some mechanisms affecting the yield of oxidative phosphorylation: Dependence upon both fluxes and forces , 1998, Molecular and Cellular Biochemistry.
[124] J. McGarry,et al. Glucose-fatty acid interactions in health and disease. , 1998, The American journal of clinical nutrition.
[125] L. Hue,et al. Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart. , 1998, The Journal of clinical investigation.
[126] D. Hardie,et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.
[127] C. Rosiers,et al. A 13C Mass Isotopomer Study of Anaplerotic Pyruvate Carboxylation in Perfused Rat Hearts* , 1997, The Journal of Biological Chemistry.
[128] E. Coyle,et al. Fatty acid oxidation is directly regulated by carbohydrate metabolism during exercise. , 1997, The American journal of physiology.
[129] B. Kemp,et al. Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.
[130] F. V. van Nieuwenhoven,et al. Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. , 1997, Journal of lipid research.
[131] M. Palacín,et al. Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes , 1997, The Journal of Biological Chemistry.
[132] D. Hardie,et al. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. , 1997, The American journal of physiology.
[133] M. Sugden,et al. Pyruvate inhibition of pyruvate dehydrogenase kinase , 1996, FEBS letters.
[134] K. Petersen,et al. Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.
[135] L. Witters,et al. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. , 1996, Biochimica et biophysica acta.
[136] J Auwerx,et al. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. , 1996, Journal of lipid research.
[137] S. Pentyala,et al. Effect of oxaloacetate and phosphorylation on ATP-citrate lyase activity. , 1995, Biochemistry.
[138] G. Lopaschuk,et al. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. , 1994, The American journal of physiology.
[139] M. Brand,et al. The causes and functions of mitochondrial proton leak. , 1994, Biochimica et biophysica acta.
[140] E. Van Schaftingen,et al. Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[141] J. E. Lawson,et al. Molecular cloning and expression of the catalytic subunit of bovine pyruvate dehydrogenase phosphatase and sequence similarity with protein phosphatase 2C. , 1993, Biochemistry.
[142] M. Rider,et al. Role of fructose 2,6-bisphosphate in the control of heart glycolysis. , 1993, The Journal of biological chemistry.
[143] M. Birnbaum,et al. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. , 1993, The Journal of biological chemistry.
[144] M. Berry,et al. Effects of fatty acid oxidation on glucose utilization by isolated hepatocytes , 1993, FEBS letters.
[145] J. McGarry,et al. What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.
[146] R. Palfreyman,et al. Kinetic resolution of the separate GLUT1 and GLUT4 glucose transport activities in 3T3-L1 cells. , 1992, The Biochemical journal.
[147] R. Shulman,et al. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[148] Christine Dreyer,et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.
[149] H. Taegtmeyer,et al. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. , 1991, The American journal of physiology.
[150] E. Van Schaftingen,et al. Competitive inhibition of liver glucokinase by its regulatory protein. , 1991, European journal of biochemistry.
[151] J. Eckel,et al. Induction of insulin resistance in primary cultured adult cardiac myocytes. , 1991, Endocrinology.
[152] C. Nobes,et al. The mechanism of stimulation of respiration by fatty acids in isolated hepatocytes. , 1990, The Journal of biological chemistry.
[153] C. Nobes,et al. Non-ohmic proton conductance of the mitochondrial inner membrane in hepatocytes. , 1990, The Journal of biological chemistry.
[154] M. Brand. The proton leak across the mitochondrial inner membrane. , 1990, Biochimica et biophysica acta.
[155] J. Duszyński,et al. Regulation of mitochondrial resting state respiration: slip, leak, heterogeneity? , 1990, Biochimica et biophysica acta.
[156] J. Mccormack,et al. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. , 1990, Physiological reviews.
[157] H. O. Spivey,et al. Substrate channeling of NADH and binding of dehydrogenases to complex I. , 1989, The Journal of biological chemistry.
[158] A. L. Kerbey,et al. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. , 1988, Diabetes/metabolism reviews.
[159] A. Sherry,et al. Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy. , 1988, The Journal of biological chemistry.
[160] M. Rider,et al. Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle. , 1988, The Biochemical journal.
[161] M. Rider,et al. Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. , 1987, The Biochemical journal.
[162] J. Mccormack,et al. Role of Ca2+ ions in the regulation of intramitochondrial metabolism in rat heart. Evidence from studies with isolated mitochondria that adrenaline activates the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes by increasing the intramitochondrial concentration of Ca2+. , 1984, The Biochemical journal.
[163] Jack E. Baldwin,et al. The evolution of metabolic cycles , 1981, Nature.
[164] J C Stanley,et al. The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.
[165] G. Brooks,et al. Glycogen repletion following continuous and intermittent exercise to exhaustion. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.
[166] H A Krebs,et al. Utilization of energy-providing substrates in the isolated working rat heart. , 1980, The Biochemical journal.
[167] J. McGarry,et al. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. , 1977, The Journal of clinical investigation.
[168] S. Cheema-Dhadli,et al. Properties of the citrate transporter in rat heart: implications for regulation of glycolysis by cytosolic citrate. , 1976, Canadian journal of biochemistry.
[169] C. Hales,et al. The inhibition of rat liver glucokinase by palmitoyl-CoA. , 1969, Biochimica et biophysica acta.
[170] E. Newsholme,et al. Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. , 1964, The Biochemical journal.
[171] J. Williamson. METABOLIC EFFECTS OF EPINEPHRINE IN THE ISOLATED, PERFUSED RAT HEART. I. DISSOCIATION OF THE GLYCOGENOLYTIC FROM THE METABOLIC STIMULATORY EFFECT. , 1964, The Journal of biological chemistry.
[172] E. Newsholme,et al. Citrate as an Intermediary in the Inhibition of Phosphofructokinase in Rat Heart Muscle by Fatty Acids, Ketone Bodies, Pyruvate, Diabetes and Starvation , 1963, Nature.
[173] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[174] E. C. Slater,et al. Uncoupling activity of long-chain fatty acids. , 1962, Biochimica et biophysica acta.
[175] E. Newsholme,et al. Effect of Fatty Acids, Ketone Bodies, Diabetes and Starvation on Pyruvate Metabolism in Rat Heart and Diaphragm Muscle , 1962, Nature.
[176] J. Williamson. Effects of insulin and diet on the metabolism of L-lactate and glucose by the perfused rat heart. , 1962, The Biochemical journal.
[177] E. Newsholme,et al. Inhibition of the Phosphofructokinase Reaction in Perfused Rat Heart by Respiration of Ketone Bodies, Fatty Acids and Pyruvate , 1962, Nature.
[178] Louise Lantier,et al. AMPK: Lessons from transgenic and knockout animals. , 2009, Frontiers in bioscience.
[179] O. Ilkayeva,et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.
[180] J. Friedman,et al. Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2008 .
[181] J. Auwerx,et al. PPARgamma in human and mouse physiology. , 2007, Biochimica et biophysica acta.
[182] A. Bonen,et al. Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins , 2007, Lipids.
[183] Xianlin Han,et al. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. , 2007, The Journal of clinical investigation.
[184] M. Rigoulet,et al. Mechanisms of mitochondrial response to variations in energy demand in eukaryotic cells. , 2007, American journal of physiology. Cell physiology.
[185] A. Warley,et al. A reevaluation of the roles of hexokinase I and II in the heart. , 2007, American journal of physiology. Heart and circulatory physiology.
[186] S. Kersten,et al. PPARalpha and dyslipidemia. , 2007, Biochimica et biophysica acta.
[187] A. Means,et al. Chutes and Ladders: the search for protein kinases that act on AMPK. , 2006, Trends in biochemical sciences.
[188] D. Carling,et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.
[189] P. Byphili,et al. Metabolic fuel selection: general integration at the whole-body level , 2005 .
[190] B. Viollet,et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. , 2003, The Journal of clinical investigation.
[191] J. McGarry. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.
[192] B. Goodpaster,et al. Muscle triglyceride and insulin resistance. , 2002, Annual review of nutrition.
[193] Xianlin Han,et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.
[194] J. Olefsky,et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[195] S.. Specific Inhibition of Glucokinase by Long Chain Acyl Coenzymes A below the Critical Micelle Concentration * , 2001 .
[196] B. Ames,et al. Part X • Chapter 27 – Oxidants and aging , 2000 .
[197] W. Wahli,et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. , 1999, The Journal of clinical investigation.
[198] K. M. Popov,et al. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. , 1998, The Biochemical journal.
[199] M. Carlson,et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.
[200] D. Moller,et al. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. , 1998, Endocrinology.
[201] A. Mahfoudi,et al. Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.
[202] L. Hue,et al. Role of fructose 2,6-bisphosphate in the control of glycolysis. Stimulation of glycogen synthesis by lactate in the isolated working rat heart. , 1993, Acta cardiologica.
[203] H. O. Spivey,et al. Substrate channeling of NADH in mitochondrial redox processes. , 1992, Current topics in cellular regulation.
[204] H. Keller,et al. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. , 1992, Cell.
[205] A. Schoolwerth,et al. Metabolite transport in mitochondria. , 1979, Annual review of biochemistry.
[206] P. J. Randle,et al. Regulation of Glucose Uptake by Muscle , 1962 .
[207] P. Iynedjian. Cellular and Molecular Life Sciences Review Molecular Physiology of Mammalian Glucokinase , 2022 .